General Information of the Compound
| Compound ID |
CP0388167
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(4-(4-chlorophenyl)-2-phenylthiazol-5-yl)acetic acid
Show/Hide
|
||||||||||||||||||
| Synonyms |
0YHF6E6NLS
18046-21-4
2-(4-(4-chlorophenyl)-2-phenylthiazol-5-yl)acetic acid
4-(4-Chlorophenyl)-2-phenyl-5-thiazoleacetic acid
4-(p-Chlorophenyl)-2-phenyl-5-thiazoleacetic acid
5-Thiazoleacetic acid, 4-(4-chlorophenyl)-2-phenyl-
5-Thiazoleacetic acid, 4-(p-chlorophenyl)-2-phenyl-
BR 700
BRN 1083610
C17H12ClNO2S
CH 800
CHEMBL589092
Donorest
EINECS 241-958-1
FENTIAZAC
Fentiazac
Fentiazaco [INN-Spanish]
Fentiazacum [INN-Latin]
Flogene
MLS003115545
NCGC00182976-01
NSC 282191
Norvedan
UNII-0YHF6E6NLS
WY 21,894
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H12ClNO2S
|
||||||||||||||||||
| Molecular Weight |
329.808
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)Cc1sc(nc1-c1ccc(Cl)cc1)-c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H12ClNO2S/c18-13-8-6-11(7-9-13)16-14(10-15(20)21)22-17(19-16)12-4-2-1-3-5-12/h1-9H,10H2,(H,20,21)
Show/Hide
|
||||||||||||||||||
| InChIKey |
JIEKMACRVQTPRC-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
18046-21-4
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound